Skip to main content

United States News All stories

Every story in this section, newest first — page 260 of 373.

Grafa
Health

Tenax Therapeutics randomizes 230 patients in pivotal Phase 3 LEVEL study

Tenax Therapeutics (NASDAQ:TENX), a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases, announced a major clinical milestone in its Phase 3 LEVEL trial.

Read more: Tenax Therapeutics randomizes 230 patients in pivotal Phase 3 LEVEL study